Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Peripartum cardiomyopathy (PPCM) is an idiopathic, potentially fatal form of dilated cardiomyopathy that develops during the final month of pregnancy or within five months after delivery.
Biomarker and diagnostic research for peripartum cardiomyopathy has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
3 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE4. Research is primarily sponsored by academic and government institutions.
244 publications have been identified in PubMed for peripartum cardiomyopathy. Research spans Review / Meta-Analysis (27%), Epidemiology / Natural History (24%), and Case Report / Case Series (21%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 66 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 6:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression | 59 | 24% |
Patient case studies | 51 | 21% |
Clinical study results | 21 | 9% |
Testing and diagnosis research | 18 | 7% |
Laboratory research | 17 | 7% |
Other research | 9 | 4% |
New treatment approaches | 3 | 1% |
Sayles NM (2026). [PMID: 41850395](https://pubmed.ncbi.nlm.nih.gov/41850395/). *Mol Metab*. [Basic Science / Preclinical]
Marano G (2026). [PMID: 41752874](https://pubmed.ncbi.nlm.nih.gov/41752874/). *Life (Basel)*. [Review / Meta-Analysis]
Umerjikar S (2026). [PMID: 42255812](https://pubmed.ncbi.nlm.nih.gov/42255812/). *Cureus*. [Diagnostic / Biomarker]
Kandemir YB (2026). [PMID: 41893331](https://pubmed.ncbi.nlm.nih.gov/41893331/). *Metabolites*. [Diagnostic / Biomarker]
Kohno Y (2026). [PMID: 41272123](https://pubmed.ncbi.nlm.nih.gov/41272123/). *Hypertens Res*. [Epidemiology / Natural History]
Lamparter LE (2026). [PMID: 42110686](https://pubmed.ncbi.nlm.nih.gov/42110686/). *J Educ Teach Emerg Med*. [Epidemiology / Natural History]
Kurt H (2026). [PMID: 41728227](https://pubmed.ncbi.nlm.nih.gov/41728227/). *Eur Heart J Case Rep*. [Case Report / Case Series]
Tolu-Akinnawo OZ (2026). [PMID: 41902617](https://pubmed.ncbi.nlm.nih.gov/41902617/). *J Womens Health (Larchmt)*. [Epidemiology / Natural History]
Karaye KM (2026). [PMID: 41778486](https://pubmed.ncbi.nlm.nih.gov/41778486/). *Ann Afr Med*. [Epidemiology / Natural History]
Hermans SP (2026). [PMID: 41844488](https://pubmed.ncbi.nlm.nih.gov/41844488/). *JACC Adv*. [Review / Meta-Analysis]
AI-curated news mentioning peripartum cardiomyopathy
Updated Mar 25, 2026
A new study evaluates women with peripartum or dilated cardiomyopathy and their first-degree relatives, contributing to the understanding of these conditions. The DCM Precision Medicine Study aims to enhance precision medicine approaches for affected families.